Sofinnova Investments’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-95,375	Closed	-$1.51M	–	74
2024 Q4	$1.51M	Buy	+95,375	New	+$1.51M	0.11%	49
2023 Q2	–	Sell	-77,100	Closed	-$3.29M	–	53
2023 Q1	$3.29M	Buy	+77,100	New	+$3.29M	0.21%	43